Superworth

Quanterix EPS QTRX

Diluted earnings per share by quarter and over the last twelve months, from 2017.

Last 12 months, to Jun 30, 2026
−$2.63
Latest quarter, Q2 FY26
−$1.04
Fiscal year 2025
−$2.52

Quanterix's earnings per share was −$2.63 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$1.04.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$2.52n/a
FY2024−$1.00n/a
FY2023−$0.75n/a
FY2022−$2.70n/a
FY2021−$1.60n/a
FY2020−$1.08n/a
FY2019−$1.64n/a
FY2018−$1.44n/a
FY2017−$10.58n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$1.04n/a−$2.63
Q1 FY26−$0.37n/a−$2.36
Q4 FY25−$0.49n/a−$2.52
Q3 FY25−$0.73n/a−$2.33
Q2 FY25−$0.77n/a−$1.82
Q1 FY25−$0.53n/a−$1.24
Q4 FY24−$0.30n/a−$1.00
Q3 FY24−$0.22n/a−$0.93
Q2 FY24−$0.19n/a−$0.89
Q1 FY24−$0.29n/a−$0.85
Q4 FY23−$0.23n/a−$0.75
Q3 FY23−$0.18n/a−$1.01

Against its peers

Companies in Healthcare nearest Quanterix's size, closest first, today.

CompanyEPS, 12 monthsGrowth
QTRXQuanterix−$2.63
KEQUKewaunee Scientific$2.76−33% a year
ICCCImmucell$0.08−58% a year
PDEXPro DEX$4.11+52% a year
PLXProtalix BioTherapeutics$0.23+283% a year
NATRNatures Sunshine Products$1.01+36% a year
ELMDElectromed$1.31+56% a year
UTMDUtah Medical Products$3.28−12% a year
LFVNLifevantage$0.40−46% a year
INFUInfuSystem$0.41+78% a year
SPROSpero Therapeutics$0.11
Peer median$0.71

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Quanterix

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.